List view / Grid view

Novo Nordisk

Saxenda demonstrates significant improvements in cardiometabolic risk factors

5 April 2016 | By Victoria White

In a three year trial, individuals treated with Saxenda lost more weight (6.1%) than those treated with placebo (1.9%)...

news

New data for semaglutide and liraglutide presented at ENDO 2016

2 April 2016 | By Victoria White

Semaglutide significantly improved glycaemic control compared to placebo in adults with type 2 diabetes previously managed with diet and exercise alone...

news

Study shows Victoza reduces the risk of major adverse cardiovascular events

4 March 2016 | By Victoria White

Victoza (liraglutide) was studied over a period of up to 5 years in more than 9,000 adults with type 2 diabetes at high risk of major adverse cardiovascular events...

news

Xultophy cost-effective versus current basal insulin intensification treatments

3 March 2016 | By Victoria White

New findings show that Xultophy is cost-effective versus current insulin intensification treatment options for the treatment of people in the UK with type 2 diabetes...

news

Headline results from SWITCH 2 trial of Tresiba announced

29 January 2016 | By Victoria White

SWITCH 2 is the first of two trials comparing the safety and efficacy of Tresiba (insulin degludec) and insulin glargine in patients with type 2 diabetes...

news

Novo Nordisk announces results for SUSTAIN2 trial of semaglutide

17 December 2015 | By Victoria White

The trial investigated the efficacy and safety of semaglutide compared with sitagliptin after 56 weeks of treatment in people with type 2 diabetes...

news

Novo Nordisk submits NDA for faster-acting insulin aspart

10 December 2015 | By Victoria White

Faster-acting insulin aspar is an investigational mealtime insulin developed by Novo Nordisk for the control of blood sugar levels in adults with type 1 and type 2 diabetes...

news

Novo Nordisk submits MAA for faster-acting insulin aspart

4 December 2015 | By Victoria White

Faster-acting insulin aspart is a mealtime insulin for improved control of postprandial glucose excursions and has been developed for the treatment of people with type 1 and type 2 diabetes...

news

Victoza provides greater glycaemic control than SGLT-2 inhibitors

2 December 2015 | By Victoria White

Novo Nordisk has released new data that shows Victoza (liraglutide) provides a greater HbA1c reduction and an improved likelihood of reaching glycaemic goals compared to sodium-glucose cotransporter 2 inhibitors...

news

Study prompts rethink on the rise of diabetes in cities

16 November 2015 | By Victoria White

New research shows socio-cultural factors including time pressure, commuting time and where you live play significant roles in diabetes vulnerability...

news

Novo Nordisk presents findings of obesity care study

5 November 2015 | By Victoria White

Results from the study highlight a general lack of understanding of obesity as a disease and its impact on the body...

news

Saxenda demonstrates significant and sustained weight loss over three years

4 November 2015 | By Victoria White

Saxenda in combination with reduced-calorie diet and increased physical activity also delayed the onset of type 2 diabetes in the three-year extension trial...

news

Novo Nordisk completes second Phase 3a trial with semaglutide

25 September 2015 | By Victoria White

The trial investigated the efficacy and safety of semaglutide compared with exenatide in 813 people with type 2 diabetes...

news

Novo Nordisk to build new manufacturing plant in Iran

24 September 2015 | By

The project is expected to last five years and represents a Novo Nordisk investment of approximately 70 million euros...

news

Xultophy trial shows improvements in patient-reported outcomes

17 September 2015 | By Victoria White

The DUAL V trial evaluated the efficacy and safety of Xultophy compared to insulin glargine U100 in adults with type 2 diabetes...

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Novo Nordisk